Please assess the completion status of the following clinical trial:

Trial Title: Nebivolol in Patients With Systolic Stage 2 Hypertension

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* male of female, 18 to 64 years of age at screening~* mean seated heart rate at least 60 bpm~* diagnosed systolic stage 2 hypertension~* unremarkable physical exam findings~Exclusion Criteria:~* high risk due to secondary hypertension or former stage 3 hypertension by JNC6~* concurrent conditions (reno, cardiovascular, obesity, thyroid, etc)~* currently taking medication that cannot be stopped during the course of the study~* participating other clinical trials~* member of the study center personnel~* documented drug abuse~* contra indication to beta blocker~* abnormal lab finding~* poor compliance~* other conditions judged by investigator that is not suitable for the study

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 64 Years
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): None
- 2 (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).